Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice (Q44225308)

1 December 2017

Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice (English)

1 reference

1 December 2017

1 reference

Ying Lan Zhao

1

1 reference

1 December 2017

Jun Du

2

1 reference

1 December 2017

Hiroaki Kanazawa

3

1 reference

1 December 2017

Xiao Bo Cen

4

1 reference

1 December 2017

Kenji Takagi

5

1 reference

1 December 2017

Kiyoyuki Kitaichi

6

1 reference

1 December 2017

Yasuaki Tatsumi

7

1 reference

1 December 2017

Kenzo Takagi

8

1 reference

1 December 2017

Michio Ohta

9

1 reference

1 December 2017

Takaaki Hasegawa

10

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

1 December 2017

1 reference

1 December 2017

956

1 reference

1 December 2017

2

1 reference

1 December 2017

246-253

1 reference

Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Metabolism of doxorubicin and epirubicin in adult human hepatocytes in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Interaction of P-glycoprotein with a hydrophobic component of rat urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Metabolism of 4'-modified analogs of doxorubicin. unique glucuronidation pathway for 4'-epidoxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood-inner ear barrier in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

7 January 2021

Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

7 January 2021

Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

7 January 2021

Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903546-1

7 January 2021

10.1016/S0006-8993(02)03546-1

Identifiers

DOI

1 reference

1 December 2017

1 reference